Bekker, P., Keshav, S., Wei, Z., Ertl, L., Wang, Y., Lai, N., . . . Schall, T. (2007). Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease.
Citación estilo ChicagoBekker, P., S. Keshav, Z. Wei, L. Ertl, Y. Wang, N. Lai, J. Wright, S. Ungashe, and T. Schall. Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease. 2007.
Cita MLABekker, P., et al. Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease. 2007.
Warning: These citations may not always be 100% accurate.